Literature DB >> 87488

Mechanisms of idiotype suppression. I. In vitro generation of idiotype-specific suppressor T cells by anti-idiotype antibodies and specific antigen.

B S Kim.   

Abstract

Normal BALB/c spleen cells are unresponsive in vitro to the phosphorylcholine (PC) determinant in the presence of anti-idiotype antibodies specific for the TEPC-15 myeloma protein (T15) which carries an idiotypic determinant indistinguishable from that of most anti-PC antibodies in BALB/c mice. The possibility that idiotype-specific suppressor cells may be generated during the culture period was examined by coculturing the cells with untreated syngeneic spleen cells. Cells that had been preincubated with anti-T15 idiotype (anti-T15id) antibodies and a PC-containing antigen, R36a for 3 d, were capable of specifically suppressing the anti-PC response of fresh normal spleen cells, indicating that idiotype-specific suppressor cells were generated during the culture period. The presence of specific antigen also appeared to be necessary because anti-T15id antibodies and a control antigen, DNP-Lys-Ficoll, were not capable of generating such suppressor cells. Suppressor cells were induced only in the population of spleen cells nonadherent to nylon wool and the suppressive activity was abrogated by treatment with anti-Thy 1.2 serum and complement. These results indicate that anti-idiotype antibodies and specific antigen can generate idiotype-specific suppressor T cells in vitro. These in vitro results may reflect in vivo mechanisms of idiotype suppression.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 87488      PMCID: PMC2184896          DOI: 10.1084/jem.149.6.1371

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Plaque formation in agar by single antibody-producing cells.

Authors:  N K JERNE; A A NORDIN
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

2.  Analysis of the cellular basis of idiotype-specific suppression.

Authors:  K Ward; H Cantor; A Nisonoff
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

Review 3.  Antigen-binding myeloma proteins in mice.

Authors:  M Potter
Journal:  Ann N Y Acad Sci       Date:  1971-12-31       Impact factor: 5.691

4.  DNP-Lys-ficoll: a T-independent antigen which elicits both IgM and IgG anti-DNP antibody-secreting cells.

Authors:  R Sharon; P R McMaster; A M Kask; J D Owens; W E Paul
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

5.  Production of large amounts of antibodies in individual mice.

Authors:  A S Tung; S T Ju; S Sato; A Nisonoff
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

6.  Anti-idiotype induced regulation of helper cell function for the response to phosphorylcholine in adult BALB/c mice.

Authors:  K Bottomly; B J Mathieson; D E Mosier
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

7.  Presence on idiotype-specific suppressor T cells of receptors that interact with molecules bearing the idiotype.

Authors:  F L Owen; S T Ju; A Nisonoff
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

8.  A requirement for antigen-specific helper T cells in the generation of cytotoxic T cells from thymocyte precursors.

Authors:  L M Pilarski
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

9.  Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice.

Authors:  H Cantor; L McVay-Boudreau; J Hugenberger; K Naidorf; F W Shen; R K Gershon
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  Phosphorylcholine-specific helper T cells in mice with an X-linked defect of antibody production to the same hapten.

Authors:  R B Kaplan; J Quintáns
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Autoregulation of immune responses via idiotype network interactions.

Authors:  L S Rodkey
Journal:  Microbiol Rev       Date:  1980-12

2.  Anti-idiotype regulation of the formation of IgE antibody to timothy grass pollen. II. In vitro induction of suppressor T cells in mini-Marbrook cultures.

Authors:  A Malley; D W Dresser
Journal:  Immunology       Date:  1983-01       Impact factor: 7.397

3.  Demonstration of anti-idiotypic antibodies directed against IgM rheumatoid factor in the serum of rheumatoid arthritis patients.

Authors:  W K Hancock; E V Barnett
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements.

Authors:  W J Koopman; R E Schrohenloher; J C Barton; E C Greenleaf
Journal:  J Clin Invest       Date:  1983-10       Impact factor: 14.808

5.  Feedback suppression of the immune response in vitro. II. IgVH-restricted antibody-dependent suppression.

Authors:  R H Zubler; B Benacerraf; R N Germain
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

6.  Antiidiotype stimulation of antigen-specific antigen-independent antibody responses in vitro. I. Evidence for stimulation of helper T lymphocyte function.

Authors:  H Z Weissberger; R R Shenk; H B Dickler
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

7.  Selective suppression of the major idiotypic component of an antihapten response by soluble T cell-derived factors with idiotypic or anti-idiotypic receptors.

Authors:  Y Hirai; A Nisonoff
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

8.  Hapten-specific T cell responses to 4-hydroxy-3-nitrophenyl acetyl. V. Role of idiotypes in the suppressor pathway.

Authors:  J Z Weinberger; R N Germain; B Benacerraf; M E Dorf
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

9.  Suppression of interstitial nephritis by auto-anti-idiotypic immunity.

Authors:  E G Neilson; M Phillips
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.